Bolognesi M, Sacerdoti D, Bombonato G, Angeli P, Gerunda G, Merenda R, Volpin R, Iemmolo R, Gatta A
Clinica Medica V, University of Padua, Italy.
Hepatology. 1998 Mar;27(3):674-8. doi: 10.1002/hep.510270306.
Splenic Doppler impedance indices are influenced, in portal hypertensive patients, by the resistance of the portal system. The aim of the study was to verify the usefulness of these indices in evaluating the presence of a pathological increase in portal resistance in patients with complications after liver transplantation. Splenic impedance indices have been evaluated in 46 patients before orthotopic liver transplantation (OLT), and 2 days, 1, 4, 8, and 12 to 18 months after transplantation. The results showed that spleen size slowly decreased after liver transplantation. From a baseline longitudinal diameter value of 18.0+/-3.6 cm (M+/-SD), the decrease was by 0%+/-3%, 8%+/-8%, 13%+/-9%, 15%+/-11%, and 14%+/-11% at 2 days and 1, 4, 8, and 12 to 18 months after liver transplantation. Splenic impedance indices-resistance index = (peak systolic - end diastolic) / peak systolic velocity; pulsatility index = (peak systolic - end diastolic) / mean velocity-which were increased before liver transplantation, showed a rapid decrease to normal values: resistance index: from 0.62+/-0.08 to 0.55+/-0.08 after 2 days, and to 0.49+/-0.09, 0.51+/-0.10, 0.54+/-0.10, 0.55+/-0.11 after 1, 4, 8, 12-18 months; pulsatility index: from 0.96+/-0.21 to 0.82+/-0.17 after 2 days, and to 0.69+/-0.19,0.72+/-0.21, 0.81+/-0.26, 0.84+/-0.26 after 1, 4, 8, and 12 to 18 months. Patients who had a good outcome, without any major complications, showed a clear and steady decrease in splenic impedance indices. On the contrary, patients who had complications affecting portal resistance (e.g., acute rejection, relapse of chronic hepatitis C virus-related hepatitis or cirrhosis, stenosis of portal anasthomosis, portal thrombosis), showed a lack of decrease, or, after an initial decrease, a subsequent re-increase in splenic impedance indices to pathological values. Splenic impedance indices measured in patients with complications were higher than those of patients without complications (P < .0004). Specificity and sensitivity of splenic impedance indices in the evaluation of the presence of complications increasing portal resistance were good. In conclusion, after OLT, splenic impedance indices could be useful aspecific parameters for identifying patients with complications that are able to affect or increase portal resistance.
在门静脉高压患者中,脾脏多普勒阻抗指数受门静脉系统阻力的影响。本研究的目的是验证这些指数在评估肝移植术后并发症患者门静脉阻力病理性增加方面的有用性。对46例原位肝移植(OLT)术前、术后2天、1个月、4个月、8个月以及12至18个月的患者进行了脾脏阻抗指数评估。结果显示,肝移植后脾脏大小缓慢减小。从基线纵向直径值18.0±3.6 cm(均值±标准差)开始,术后2天、1个月、4个月、8个月以及12至18个月时的减小幅度分别为0%±3%、8%±8%、13%±9%、15%±11%和14%±11%。脾脏阻抗指数——阻力指数=(收缩期峰值-舒张末期)/收缩期峰值速度;搏动指数=(收缩期峰值-舒张末期)/平均速度——在肝移植术前升高,术后迅速降至正常水平:阻力指数:术后2天从0.62±0.08降至0.55±0.08,术后1个月、4个月、8个月以及12至18个月分别降至0.49±0.09、0.51±0.10、0.54±0.10、0.55±0.11;搏动指数:术后2天从0.96±0.21降至0.82±0.17,术后1个月、4个月、8个月以及12至18个月分别降至0.69±0.19、0.72±0.21、0.81±0.26、0.84±0.26。预后良好且无任何严重并发症的患者,其脾脏阻抗指数呈现明显且稳定的下降。相反,出现影响门静脉阻力的并发症(如急性排斥反应、丙型肝炎病毒相关性肝炎或肝硬化复发、门静脉吻合口狭窄、门静脉血栓形成)的患者,其脾脏阻抗指数没有下降,或者在最初下降后,随后又重新升高至病理值。有并发症患者的脾脏阻抗指数高于无并发症患者(P<0.0004)。脾脏阻抗指数在评估增加门静脉阻力的并发症方面具有良好的特异性和敏感性。总之,OLT术后,脾脏阻抗指数可作为识别可能影响或增加门静脉阻力的并发症患者的特异性参数。